University of Sussex
Browse

File(s) not publicly available

The creation of neo-liberal corporate bias in transnational medicines control: the industrial shaping and interest dynamics of the European regulatory state

journal contribution
posted on 2023-06-08, 05:12 authored by John Abraham
Drawing on the political theories of corporatism, neo-liberalism and pluralism, and on comparative empirical research in Brussels, Germany, Sweden and the UK, this article conceptualises the nature of Europeanised medicines regulation. It argues that a marketisation of regulation has been established in the European Union as a result of competition between national regulatory agencies for `regulatory business' from the pharmaceutical industry. In the pharmaceuticals sector the Europeanised regulatory state is a product of three key factors: (a) the European Commission's commitment to an `efficiency' regime which would meet the political objectives of a single European market and the commercial agendas of transnational pharmaceutical companies, (b) the endemic corporate bias associated with medicines regulation in the most influential member states, and (c) the considerable success of neo-liberal politics across a number of major member states, including Germany, Sweden and the United Kingdom.

History

Publication status

  • Published

Journal

European Journal of Political Research

ISSN

03044130

Publisher

Wiley-Blackwell

Issue

1

Volume

39

Page range

53-80

Pages

28.0

Department affiliated with

  • Sociology and Criminology Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date

2012-02-06

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC